{"id":49640,"date":"2022-10-14T14:02:06","date_gmt":"2022-10-14T12:02:06","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-t-cell-lymphoma-market-to-grow-by-768-07-million-during-2022-2026-researchandmarkets-com\/"},"modified":"2022-10-14T14:02:06","modified_gmt":"2022-10-14T12:02:06","slug":"global-t-cell-lymphoma-market-to-grow-by-768-07-million-during-2022-2026-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-t-cell-lymphoma-market-to-grow-by-768-07-million-during-2022-2026-researchandmarkets-com\/","title":{"rendered":"Global T-cell Lymphoma Market to Grow by $768.07 Million During 2022-2026 &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5659388\/global-t-cell-lymphoma-market-2022-2026?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=mtd84z&amp;utm_campaign=1762300+-+Global+T-cell+Lymphoma+Market+to+Grow+by+%24768.07+Million+During+2022-2026&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Global T-cell lymphoma Market 2022-2026&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20221014005254\/en\/1602297\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221014005254\/en\/1602297\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe T-cell lymphoma market is poised to grow by $768.07 mn during 2022-2026, accelerating at a CAGR of 8.21% during the forecast period. The report on the T-cell lymphoma market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.\n<\/p>\n<p>\nThe report offers an up-to-date analysis of the current global market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the growing geriatric population, increasing approval of therapeutics for patients with relapsed or refractory T-cell lymphoma, and increasing incidence of T-cell lymphoma.\n<\/p>\n<p>\nThe T-cell lymphoma market analysis includes the type segment and geographic landscape.\n<\/p>\n<p>\n<strong>The T-cell lymphoma market is segmented as below:<\/strong>\n<\/p>\n<p>\n<strong>By Type<\/strong>\n<\/p>\n<ul>\n<li>\nPeripheral T-cell lymphomas\n<\/li>\n<li>\nT-cell lymphoblastic lymphoma\n<\/li>\n<\/ul>\n<p>\n<strong>By Geographical Landscape<\/strong>\n<\/p>\n<ul>\n<li>\nNorth America\n<\/li>\n<li>\nEurope\n<\/li>\n<li>\nAsia\n<\/li>\n<li>\nRest of World (ROW)\n<\/li>\n<\/ul>\n<p>\nThis study identifies technological advancements as one of the prime reasons driving the T-cell lymphoma market growth during the next few years. Also, increasing patient support programs and strategic alliances will lead to sizable demand in the market.\n<\/p>\n<p>\n<strong>The report on the T-cell lymphoma market covers the following areas:<\/strong>\n<\/p>\n<ul>\n<li>\nT-cell lymphoma market sizing\n<\/li>\n<li>\nT-cell lymphoma market forecast\n<\/li>\n<li>\nT-cell lymphoma market industry analysis\n<\/li>\n<\/ul>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<p>\n<strong>1 Executive Summary<\/strong>\n<\/p>\n<p>\n<strong>2 Market Landscape<\/strong>\n<\/p>\n<p>\n<strong>3 Market Sizing<\/strong>\n<\/p>\n<p>\n<strong>4 Five Forces Analysis<\/strong>\n<\/p>\n<p>\n<strong>5 Market Segmentation by Type<\/strong>\n<\/p>\n<p>\n<strong>6 Customer Landscape<\/strong>\n<\/p>\n<p>\n<strong>7 Geographic Landscape<\/strong>\n<\/p>\n<p>\n<strong>8 Drivers, Challenges, and Trends<\/strong>\n<\/p>\n<p>\n<strong>9 Vendor Landscape<\/strong>\n<\/p>\n<p>\n<strong>10 Vendor Analysis<\/strong>\n<\/p>\n<p>\n<strong>11 Appendix<\/strong>\n<\/p>\n<p>\n<strong>Companies Mentioned<\/strong>\n<\/p>\n<ul>\n<li>\nAbbVie Inc.\n<\/li>\n<li>\nAccredo Health Group Inc.\n<\/li>\n<li>\nAstraZeneca Plc\n<\/li>\n<li>\nAutolus Therapeutics Plc\n<\/li>\n<li>\nBaxter International Inc.\n<\/li>\n<li>\nBiogen Inc.\n<\/li>\n<li>\nBristol Myers Squibb Co.\n<\/li>\n<li>\nEli Lilly and Co.\n<\/li>\n<li>\nF. Hoffmann La Roche Ltd.\n<\/li>\n<li>\nGenmab AS\n<\/li>\n<li>\nGSK Plc\n<\/li>\n<li>\nH. Lee Moffitt Cancer Center and Research Institute Inc.\n<\/li>\n<li>\nJohnson and Johnson\n<\/li>\n<li>\nMacopharma SA\n<\/li>\n<li>\nMerck and Co. Inc.\n<\/li>\n<li>\nMundipharma International Ltd.\n<\/li>\n<li>\nNovartis AG\n<\/li>\n<li>\nPfizer Inc.\n<\/li>\n<li>\nSanofi\n<\/li>\n<li>\nTeva Pharmaceutical Industries Ltd.\n<\/li>\n<li>\nTYME Inc.\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5659388\/global-t-cell-lymphoma-market-2022-2026?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=mtd84z&amp;utm_campaign=1762300+-+Global+T-cell+Lymphoma+Market+to+Grow+by+%24768.07+Million+During+2022-2026&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/3hjpvw<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#105;&#x6c;t&#x6f;:&#112;&#x72;&#101;&#x73;&#115;&#x40;r&#x65;s&#101;&#x61;&#114;&#x63;h&#x61;n&#x64;&#x6d;&#97;&#x72;&#107;&#x65;t&#x73;&#46;&#99;&#x6f;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">&#x70;r&#x65;&#115;&#x73;&#64;r&#x65;s&#x65;&#97;&#x72;&#99;h&#x61;&#110;&#x64;&#109;a&#x72;k&#x65;&#116;&#x73;&#46;c&#x6f;m<\/a><br \/>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/ CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global T-cell lymphoma Market 2022-2026&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The T-cell lymphoma market is poised to grow by $768.07 mn during 2022-2026, accelerating at a CAGR of 8.21% during the forecast period. The report on the T-cell lymphoma market provides a holistic analysis, market size and forecast, trends, growth drivers, &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/global-t-cell-lymphoma-market-to-grow-by-768-07-million-during-2022-2026-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-49640","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Global T-cell Lymphoma Market to Grow by $768.07 Million During 2022-2026 - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/global-t-cell-lymphoma-market-to-grow-by-768-07-million-during-2022-2026-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Global T-cell Lymphoma Market to Grow by $768.07 Million During 2022-2026 - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global T-cell lymphoma Market 2022-2026&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The T-cell lymphoma market is poised to grow by $768.07 mn during 2022-2026, accelerating at a CAGR of 8.21% during the forecast period. The report on the T-cell lymphoma market provides a holistic analysis, market size and forecast, trends, growth drivers, ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/global-t-cell-lymphoma-market-to-grow-by-768-07-million-during-2022-2026-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-10-14T12:02:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221014005254\/en\/1602297\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-t-cell-lymphoma-market-to-grow-by-768-07-million-during-2022-2026-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-t-cell-lymphoma-market-to-grow-by-768-07-million-during-2022-2026-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Global T-cell Lymphoma Market to Grow by $768.07 Million During 2022-2026 &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-10-14T12:02:06+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-t-cell-lymphoma-market-to-grow-by-768-07-million-during-2022-2026-researchandmarkets-com\\\/\"},\"wordCount\":378,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-t-cell-lymphoma-market-to-grow-by-768-07-million-during-2022-2026-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221014005254\\\/en\\\/1602297\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-t-cell-lymphoma-market-to-grow-by-768-07-million-during-2022-2026-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-t-cell-lymphoma-market-to-grow-by-768-07-million-during-2022-2026-researchandmarkets-com\\\/\",\"name\":\"Global T-cell Lymphoma Market to Grow by $768.07 Million During 2022-2026 - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-t-cell-lymphoma-market-to-grow-by-768-07-million-during-2022-2026-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-t-cell-lymphoma-market-to-grow-by-768-07-million-during-2022-2026-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221014005254\\\/en\\\/1602297\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-10-14T12:02:06+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-t-cell-lymphoma-market-to-grow-by-768-07-million-during-2022-2026-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-t-cell-lymphoma-market-to-grow-by-768-07-million-during-2022-2026-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-t-cell-lymphoma-market-to-grow-by-768-07-million-during-2022-2026-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221014005254\\\/en\\\/1602297\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221014005254\\\/en\\\/1602297\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-t-cell-lymphoma-market-to-grow-by-768-07-million-during-2022-2026-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Global T-cell Lymphoma Market to Grow by $768.07 Million During 2022-2026 &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Global T-cell Lymphoma Market to Grow by $768.07 Million During 2022-2026 - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/global-t-cell-lymphoma-market-to-grow-by-768-07-million-during-2022-2026-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Global T-cell Lymphoma Market to Grow by $768.07 Million During 2022-2026 - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global T-cell lymphoma Market 2022-2026&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The T-cell lymphoma market is poised to grow by $768.07 mn during 2022-2026, accelerating at a CAGR of 8.21% during the forecast period. The report on the T-cell lymphoma market provides a holistic analysis, market size and forecast, trends, growth drivers, ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/global-t-cell-lymphoma-market-to-grow-by-768-07-million-during-2022-2026-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-10-14T12:02:06+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221014005254\/en\/1602297\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/global-t-cell-lymphoma-market-to-grow-by-768-07-million-during-2022-2026-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/global-t-cell-lymphoma-market-to-grow-by-768-07-million-during-2022-2026-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Global T-cell Lymphoma Market to Grow by $768.07 Million During 2022-2026 &#8211; ResearchAndMarkets.com","datePublished":"2022-10-14T12:02:06+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-t-cell-lymphoma-market-to-grow-by-768-07-million-during-2022-2026-researchandmarkets-com\/"},"wordCount":378,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-t-cell-lymphoma-market-to-grow-by-768-07-million-during-2022-2026-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221014005254\/en\/1602297\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/global-t-cell-lymphoma-market-to-grow-by-768-07-million-during-2022-2026-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/global-t-cell-lymphoma-market-to-grow-by-768-07-million-during-2022-2026-researchandmarkets-com\/","name":"Global T-cell Lymphoma Market to Grow by $768.07 Million During 2022-2026 - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-t-cell-lymphoma-market-to-grow-by-768-07-million-during-2022-2026-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-t-cell-lymphoma-market-to-grow-by-768-07-million-during-2022-2026-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221014005254\/en\/1602297\/21\/logo.jpg","datePublished":"2022-10-14T12:02:06+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/global-t-cell-lymphoma-market-to-grow-by-768-07-million-during-2022-2026-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/global-t-cell-lymphoma-market-to-grow-by-768-07-million-during-2022-2026-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/global-t-cell-lymphoma-market-to-grow-by-768-07-million-during-2022-2026-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221014005254\/en\/1602297\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221014005254\/en\/1602297\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/global-t-cell-lymphoma-market-to-grow-by-768-07-million-during-2022-2026-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Global T-cell Lymphoma Market to Grow by $768.07 Million During 2022-2026 &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49640","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=49640"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/49640\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=49640"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=49640"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=49640"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}